Adaptimmune Therapeutics PLC ADR Stock
Heavy losses for Adaptimmune Therapeutics PLC ADR today as the stock fell by -€0.080 (-7.340%).
Currently there is a rather positive sentiment for Adaptimmune Therapeutics PLC ADR with 3 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 1 € is below the current price of 1.02 € for Adaptimmune Therapeutics PLC ADR, so the potential is actually -1.96%.
Our community identified positive and negative aspects for Adaptimmune Therapeutics PLC ADR stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adaptimmune Therapeutics PLC ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adaptimmune Therapeutics PLC ADR in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adaptimmune Therapeutics PLC ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC ADR | -7.340% | -1.923% | 9.677% | -19.048% | 63.200% | -74.752% | - |
Tissue Regenix Group Plc | - | 0.000% | -0.725% | 14.167% | 21.239% | - | - |
Cicassia Pharmaceuticals | 0.610% | 1.840% | 12.162% | 31.746% | 18.571% | 125.543% | 178.523% |
Optibiotix Health plc | 3.000% | 3.000% | 1.980% | 92.523% | -29.932% | -63.214% | - |